Search

Your search keyword '"Thomalla, J"' showing total 215 results

Search Constraints

Start Over You searched for: Author "Thomalla, J" Remove constraint Author: "Thomalla, J"
215 results on '"Thomalla, J"'

Search Results

1. A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

2. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

3. Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”

4. P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL

5. Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022

6. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

7. A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study (vol 30, pg 1279, 2019)

8. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

18. Survival of patients with advanced solid tumours who are treated in community based oncology group practices is longer compared to registry data and comparable to randomized controlled trials

19. Abstract PD2-07: mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC)– Results of the translational biomarker programme of the neoadjuvant double-blind placebo controlled GeparNuevo trial

20. Abstract PD5-05: Pre-therapeutic PD-L1 expression and dynamics of Ki-67 and gene expression during neoadjuvant immune-checkpoint blockade and chemotherapy to predict response within the GeparNuevo trial

21. Abstract P1-16-06: Improved survival of patients with metastatic breast cancer in routine care is restricted to tumors with positive hormone receptor and/or Her2-expression. Survival analysis of 1,321 patients treated between 1995 and 2017 in oncology group practices

22. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

24. Abstract P6-15-01: Withdrawn

26. Die Versorgungsrealität von therapiebedürftigen Patienten mit Chronisch Lymphatischer Leukämie (CLL) in einer Schwerpunktpraxis für Hämatologie und Onkologie

28. Abstract P5-16-01: A randomised phase III trial comparing two dose-dense, dose-intensified approaches (ETC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto)

29. Die Versorgungsrealität von Patientinnen mit metastasiertem Mammakarzinom in einer onkologischen Schwerpunktpraxis

30. Compliance / Adhärenz von Patientinnen mit metastasiertem Mammakarzinom unter oraler Therapie: Wahrnehmung von Patientinnen, Angehörigen und Onkologen sowie Analyse der Verordnungsdaten

31. Hypospadias repair in elderly patients

36. Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022

37. Immunglobulinsubstitution in der Behandlung von Patienten mit follikulärem Lymphom oder Chronisch Lymphatischer Leukämie

43. Interactive medical education for medical students in an oncology group practice

50. Interaktiver Kleingruppenunterricht für Medizinstudenten der Klinischen Semester in einer onkologischen Gemeinschaftspraxis

Catalog

Books, media, physical & digital resources